Quick Answer
Eledon Pharmaceuticals, Inc. reported Net Income of -$45.62 million for fiscal year 2025.
Eledon Pharmaceuticals, Inc. Net Income — Annual History
| Fiscal Year | Net Income | YoY Change |
|---|---|---|
| 2025 | -$45.62M | -26.1% |
| 2024 | -$36.18M | +69.0% |
| 2023 | -$116.54M | -32.5% |
| 2022 | -$87.97M | -154.9% |
| 2021 | -$34.51M | -51.3% |
| 2020 | -$22.81M | -42.5% |
| 2019 | -$16.01M | -13.8% |
| 2018 | -$14.06M | -7.2% |
| 2017 | -$13.12M | -131.9% |
| 2016 | -$5.66M | +87.5% |
| 2015 | -$45.09M | -93.5% |
| 2014 | -$23.30M | -48.1% |
| 2013 | -$15.72M | -63.0% |
| 2012 | -$9.65M | — |
Quarterly Net Income
| Quarter Ending | Net Income | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$17.46M | -122.7% | -55.7% |
| June 30, 2025 | -$11.22M | +75.0% | -72.7% |
| March 31, 2025 | -$6.50M | +72.5% | -108.4% |
| September 30, 2024 | $76.97M | +877.0% | +271.4% |
| June 30, 2024 | -$44.91M | +31.7% | -90.0% |
| March 31, 2024 | -$23.63M | -119.4% | -138.6% |
| September 30, 2023 | -$9.91M | +5.4% | +84.9% |
| June 30, 2023 | -$65.76M | -611.1% | -510.5% |
- Eledon Pharmaceuticals, Inc. showed a decrease of -26.1% in Net Income compared to the prior fiscal year.
- Over the 2012–2025 period, Eledon Pharmaceuticals, Inc.’s net income has declined by 372.8% (from -$9.65 million to -$45.62 million).
- The most recent figure is from Eledon Pharmaceuticals, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 19, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: